1 – 10 of 15
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
The prognostic value of programmed death-ligand 1 (PD-L1) expression in resected colorectal cancer without neoadjuvant therapy - differences between antibody clones and cell types
(
- Contribution to journal › Article
-
Mark
Detailed analysis of metastatic colorectal cancer patients who developed cardiotoxicity on another fluoropyrimidine and switched to S-1 treatment (subgroup analysis of the CardioSwitch-study).
(
- Contribution to journal › Article
-
Mark
Postcovidmottagningar behövs både för patienter och framtida beredskap
2024) In Läkartidningen(
- Contribution to journal › Debate/Note/Editorial
- 2022
-
Mark
Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours : a multicentre retrospective observational cohort study
(
- Contribution to journal › Article
-
Mark
SOULMATE: the Swedish study of liver transplantation for isolated colorectal cancer liver metastases not suitable for operation or ablation, compared to best established treatment-a randomized controlled multicenter trial
(
- Contribution to journal › Article
-
Mark
Postinfektiösa tillstånd kräver kunskapsstyrning
2022) In Läkartidningen(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Replik: Författarna har missförstått vår avsikt
2022) In Läkartidningen(
- Contribution to journal › Debate/Note/Editorial
- 2020
-
Mark
Cost analysis comparison between peripherally inserted central catheters and implanted chest ports in patients with cancer—A health economic evaluation of the PICCPORT trial
(
- Contribution to journal › Article
-
Mark
Transplantation möjlighet vid kolorektala levermetastaser
(
- Contribution to journal › Debate/Note/Editorial
- 2019
-
Mark
Clinical impact of peripherally inserted central catheters vs implanted port catheters in patients with cancer: an open-label, randomised, two-centre trial
(
- Contribution to journal › Article